Navigation Links
Clostridium difficile Infection: Best Strategies for Care of Older Adults
Date:1/27/2009

Complimentary Continuing Education Monograph for Registered Nurses and Nurse Practitioners

VOORHEES, N.J., Jan. 27 /PRNewswire/ -- Over the past several years, the incidence and mortality rates of Clostridium difficile infection (CDI) have increased dramatically. CDI is a serious condition, particularly in older adults. Not only are older adults at increased risk for developing CDI, they also have a higher CDI-associated mortality. It is imperative that healthcare professionals be aware of the risk factors, diagnostic considerations, and treatment strategies for CDI in this patient population.

To address the need for current education on CDI in older adults, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing education monograph for registered nurses and nurse practitioners. This activity is supported by an educational grant from ViroPharma Incorporated.

Faculty for this monograph include Erik R. Dubberke, MD, Assistant Professor of Medicine in the Infectious Diseases Division of the Department of Medicine at Washington University School of Medicine and Medical Director in Infection Control at Missouri Baptist Medical Center in St. Louis, Missouri and Suzanne F. Bradley, MD, Professor of Medicine in the Department of Internal Medicine at the University of Michigan Medical School in Ann Arbor, Michigan.

Healthcare professionals can visit www.RMEI.com/CDI060 to access this continuing education monograph.

"Quality continuing education is vital to developing and increasing knowledge and skills and enhancing patient care," says Robert Michael Educational Institute LLC President and CEO, Robert M. Colleluori.

RMEI is a medical education company that specializes in independent, accredited and nonaccredited education. The goal of all accredited RMEI educational offerings is to promote a spirit of lifelong learning and continuous professional development. RMEI works closely with medical experts to design activities that improve diagnosis and treatment. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.

For other educational opportunities, please visit www.RMEI.com.


'/>"/>
SOURCE RMEI
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Clostridium difficile Infection in Long-Term Care: Tailored Approaches to Management
2. BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
3. Current Concepts in Clostridium difficile Infection: A Focus on Geriatric and Pediatric Patients
4. Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market
5. MRSA and C. difficile Infections Reduced by 50% in Hospital Study
6. New Report Shows High C-difficile Infection Rates in U.S. Hospitals
7. Advances in C. difficile research
8. APIC Launches First National C. Difficile Prevalence Study
9. APIC launches first national C. difficile prevalence study
10. National Experts Team Up to Help Hospitals Prevent and Control C. difficile Outbreaks
11. Osteotech Expands Senior Management Team; New Executives to Drive Sales Force Strategies and Therapy-Based Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... , ... The American Cleft Palate-Craniofacial Association (ACPA) is pleased to announce KLS ... longtime supporter of the event. , "We are pleased that KLS Martin is joining ... 2017 ACPA President. "KLS Martin has a long track record of support of the ...
(Date:2/23/2017)... ... 23, 2017 , ... On April 13, 2017, The ... “Doping in Sport: How the Culture Might Change,” in conjunction with Pepperdine ... will be held at Pepperdine University in Malibu, California. , Sir Philip Craven, ...
(Date:2/23/2017)... ... 23, 2017 , ... Healthcare Research & Analytics® (HRA®) in ... against cancer, has produced a seminal study that asked cancer survivors and their ... in a webinar, Defining Compassionate Care Through the Voices of Patients and Advocates ...
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today that the Blüm ... in children aged 3-8 with Autism, is now enrolling at three new sites. These ... the United States. , “There are currently no approved drugs that address the ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... and athletics. It’s enough to overwork even the sharpest brain. , Power On, ... peak healthy activity without over clocking the brain. Each capsule contains Cognizin® Citicoline, ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an ... that it has acquired exclusive worldwide rights to ... innovative HDAC inhibitor targeting hematological and solid tumors. ... Phase 1 and 2 clinical trials of Abexinostat ... have already been completed, demonstrating that Abexinostat ...
(Date:2/23/2017)...  Genesis Healthcare Services has merged with Hospice Cloud, ... Bill Monast , President and CEO of Hospice ... Feltman , executives with Home Health Depot, Inc., the ... This acquisition helps Hospice Cloud maintain its position ... medical equipment (DME) solutions for the hospice industry. ...
(Date:2/23/2017)... Nevro Corp. (NYSE: NVRO), a global medical device ... of chronic pain, today reported financial results for the three ... 2016 Accomplishment & Highlights: Achieved revenue ... of 228% as reported, over the prior year ... 612% over the prior year International revenue ...
Breaking Medicine Technology: